Brasil
| Actas de congresos
Vasorelaxing Effect Of Bay 41-2272 In Rat Basilar Artery: Involvement Of Cgmp-dependent And Independent Mechanisms
Registro en:
Hypertension. , v. 47, n. 3 II, p. 596 - 602, 2006.
0194911X
10.1161/01.HYP.0000199914.36936.1b
2-s2.0-33644981623
Autor
Teixeira C.E.
Priviero F.B.M.
Todd Jr. J.
Webb R.C.
Institución
Resumen
Decreases in intrinsic NO cause cerebral vasospasms because of the dysregulation of cGMP formation by NO-mediated pathways. Because 5-cyclopropyl-2-{1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl} pyrimidin-4-ylamine (BAY 41-2272) is a potent soluble guanylyl cyclase (sGC) stimulator in an NO-independent manner, this study aimed to investigate the mechanisms underlying the relaxant effects of BAY 41-2272 in the rat basilar artery. BAY 41-2272 (0.0001 to 1 μmol/L) induced relaxations in a concentration-dependent manner, with pEC50 values of 8.13±0.03 and 7.63±0.05 in intact and denuded rings, respectively. The sGC inhibitor 1H-[1,2,4] oxadiazolo [4,3,-a]quinoxalin-1-one (ODQ) markedly displaced the curve for BAY 41-2272 to the right in intact or denuded rings (≈10-fold). The NO synthesis inhibitor NG-nitro-L-arginine methyl ester caused a rightward shift in the curve for BAY 41-2272 (4-fold), whereas the phosphodiesterase type 5 inhibitor sildenafil enhanced BAY 41-2272-induced relaxations (3- to 4-fold). The Na+-K+-ATPase inhibitor ouabain caused 3-fold rightward shifts in the curves for BAY 41-2272. Ca 2+-induced contractions in K+ depolarized rings were significantly attenuated by BAY 41-2272 in an ODQ-insensitive manner. The NO donor glyceryl trinitrate and BAY 41-2272 caused rightward shifts in the contractile responses to serotonin. Their coincubation caused a synergistic inhibition of serotonin-induced contractions. BAY 41-2272 and glyceryl trinitrate increased cGMP levels (but not cAMP) by 10-fold and 4-fold above baseline, respectively, in an ODQ-sensitive manner. cGMP levels increased by 50-fold after coincubation. BAY 41-2272 potently relaxes the rat basilar artery in a synergistic fashion with NO. Targeting the sGC with selective activators, such as BAY 41-2272, may represent a new therapy to treat cerebrovascular disease. © 2006 American Heart Association, Inc. 47 3 II 596 602 Faraci, F.M., Brian Jr., J.E., Nitric oxide and the cerebral circulation (1994) Stroke, 25, pp. 692-703 Szabo, C., Physiological and pathophysiological roles of nitric oxide in the central nervous system (1996) Brain Res Bull, 41, pp. 131-141 Lee, T.J., Nitric oxide and the cerebral vascular function (2000) J Biomed Sci, 7, pp. 16-26 Kikkawa, K., Hoshino, T., Yamauchi-Kohno, R., Murata, S., Characteristics of heterogeneity in the expression of vasoconstriction in response to NG-monomethyl-L-arginine in isolated canine arteries (1999) Eur J Pharmacol, 379, pp. 167-173 Benyó, Z., Lacza, Z., Hortobágyi, T., Görlach, C., Wahl, M., Functional importance of neuronal nitric oxide synthase in the endothelium of rat basilar arteries (2000) Brain Res, 877, pp. 79-84 Irikura, K., Maynard, K.I., Moskowitz, M.A., Importance of nitric oxide synthase inhibition to the attenuated vascular responses induced by topical L-nitroarginine during vibrissal stimulation (1994) J Cereb Blood Flow Metab, 14, pp. 45-48 Rise, I.R., Kirkeby, O.J., Effect of reduced cerebral perfusion pressure on cerebral blood flow following inhibition of nitric oxide synthesis (1998) J Neurosurg, 89, pp. 448-453 Tao, H., Zhang, L.M., Castresana, M.R., Newman, W.H., Shillcutt, S.D., Response of cultured cerebral artery smooth muscle cells to the nitric oxide vasodilators, nitroglycerin and sodium nitroprusside (1997) J Neurosurg Anesthesiol, 9, pp. 58-64 Onoue, H., Katusic, Z.S., The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide (1998) Brain Res, 785, pp. 107-113 Okamura, T., Ayajiki, K., Fujioka, H., Shinozaki, K., Toda, N., Neurogenic cerebral vasodilation mediated by nitric oxide (2002) Jpn J Pharmacol, 88, pp. 32-38 Lucas, K.A., Pitari, G.M., Kazerounian, S., Ruiz-Stewart, I., Park, J., Schulz, S., Chepenik, K.P., Waldman, S.A., Guanylyl cyclases and signaling by cyclic GMP (2000) Pharmacol Rev, 52, pp. 375-414 Sobey, C.G., Cerebrovascular dysfunction after subarachnoid haemorrhage: Novel mechanisms and directions for therapy (2001) Clin Exp Pharmacol Physiol, 28, pp. 926-929 Pluta, R.M., Delayed cerebral vasospasm and nitric oxide: Review, new hypothesis, and proposed treatment (2005) Pharmacol Ther, 105, pp. 23-56 Hobbs, A.J., Soluble guanylate cyclase: An old therapeutic target re-visited (2002) Br J Pharmacol, 136, pp. 637-640 Zhang, R., Zhang, L., Zhang, Z., Wang, Y., Lu, M., Lapointe, M., Chopp, M., A nitric oxide donor induces neurogenesis and reduces functional deficits after stroke in rats (2001) Ann Neurol, 50, pp. 602-611 Parker, J.O., Nitrate tolerance in angina pectoris (1989) Cardiovasc Drugs Ther, 2, pp. 823-829 Stamler, J.S., Redox signaling: Nitrosylation and related target interactions of nitric oxide (1994) Cell, 78, pp. 931-936 Beckmann, J.S., Ye, Y.Z., Anderson, P.G., Chen, J., Accavitti, M.A., Tarpey, M.M., White, C.R., Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry (1994) Biol Chem Hoppe Seyler, 375, pp. 81-88 Stasch, J.P., Becker, E.M., Alonso-Alija, C., Apeler, H., Dembowsky, K., Feurer, A., Gerzer, R., Schramm, M., NO-independent regulatory site on soluble guanylate cyclase (2001) Nature, 410, pp. 212-215 Priviero, F.B.M., Baracat, J.S., Teixeira, C.E., Claudino, M.A., De Nucci, G., Antunes, E., Mechanisms underlying rabbit aorta relaxation by BAY 41-2272, a nitric oxide independent soluble guanylate cyclase activator (2005) Clin Exp Pharmacol Physiol, 32, pp. 728-734 Kasuya, H., Weir, B.K., Nakane, M., Pollock, J.S., Johns, L., Marton, L.S., Stefansson, K., Nitric oxide synthase and guanylate cyclase levels in canine basilar artery after subarachnoid hemorrhage (1995) J Neurosurg, 82, pp. 250-255 Hino, A., Tokuyama, Y., Weir, B., Takeda, J., Yano, H., Bell, G.I., Macdonald, R.L., Changes in endothelial nitric oxide synthase mRNA during vasospasm after subarachnoid hemorrhage in monkeys (1996) Neurosurgery, 39, pp. 562-567 Sobey, C.G., Faraci, F.M., Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles (1997) Stroke, 28, pp. 837-842 Didion, S.P., Heistad, D.D., Faraci, F.M., Mechanisms that produce nitric oxide-mediated relaxation of cerebral arteries during atherosclerosis (2001) Stroke, 32, pp. 761-766 Baracat, J.S., Teixeira, C.E., Okuyama, C.E., Priviero, F.B., Faro, R., Antunes, E., De Nucci, G., Relaxing effects induced by the soluble guanylyl cyclase stimulator BAY 41-2272 in human and rabbit corpus cavernosum (2003) Eur J Pharmacol, 477, pp. 163-169 Loesch, A., Burnstock, G., Ultrastructural study of perivascular nerve fibres and endothelial cells of the rat basilar artery immunolabelled with monoclonal antibodies to neuronal and endothelial nitric oxide synthase (1996) J Neurocytol, 25, pp. 525-534 Loesch, A., Burnstock, G., Perivascular nerve fibres and endothelial cells of the rat basilar artery: Immuno-gold labelling of antigenic sites for type I and type III nitric oxide synthase (1998) J Neurocytol, 27, pp. 197-204 Liu, J., Lee, T.J., Mechanism of prejunctional muscarinic receptor-mediated inhibition of neurogenic vasodilation in cerebral arteries (1999) Am J Physiol, 276, pp. H194-H204 Lee, T.J., Liu, J., Evans, M.S., Cholinergic-nitrergic transmitter mechanisms in the cerebral circulation (2001) Microsc Res Tech, 53, pp. 119-128 Zhang, Z.G., Reif, D., Macdonald, J., Tang, W.X., Kamp, D.K., Gentile, R.J., Shakespeare, W.C., Chopp, M., ARL 17477, a potent and selective neuronal NOS inhibitor decreases infarct volume after transient middle cerebral artery occlusion in rats (1996) J Cereb Blood Flow Metab, 16, pp. 599-604 Okamoto, H., Hudetz, A.G., Roman, R.J., Bosnjak, Z.J., Kampine, J.P., Neuronal NOS-derived NO plays permissive role in cerebral blood flow response to hypercapnia (1997) Am J Physiol, 272, pp. H559-H566 Hudetz, A.G., Shen, H., Kampine, J.P., Nitric oxide from neuronal NOS plays critical role in cerebral capillary flow response to hypoxia (1998) Am J Physiol, 274, pp. H982-H989 Wohlfart, P., Malinski, T., Ruetten, H., Schindler, U., Linz, W., Schoenafinger, K., Strobel, H., Wiemer, G., Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase (1999) Br J Pharmacol, 128, pp. 1316-1322 Patemo, R., Faraci, F.M., Heistad, D.D., Role of Ca2+-dependent K+ channels in cerebral vasodilatation induced by increases in cyclic GMP and cyclic AMP in the rat (1996) Stroke, 27, pp. 1603-1607 Onoue, H., Katusic, Z.S., Role of potassium channels in relaxations of canine middle cerebral arteries induced by nitric oxide donors (1997) Stroke, 28, pp. 1264-1270 Nielsen, O.B., Clausen, T., Regulation of Na+-K+ pump activity in contracting rat muscle (1997) J Physiol, 503, pp. 571-581 Bawankule, D.U., Sathishkumar, K., Sardar, K.K., Chanda, D., Krishna, A.V., Prakash, V.R., Mishra, S.K., BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridine-3-yl]pyrimidin-4-ylamine]-induced dilation in ovine pulmonary artery: Role of sodium pump (2005) J Pharmacol Exp Ther, 314, pp. 207-213 Wang, J.P., Chang, L.C., Huang, L.J., Kuo, S.C., Inhibition of extracellular Ca2+ entry by YC-1, an activator of soluble guanylyl cyclase, through a cyclic GMP-independent pathway in rat neutrophils (2001) Biochem Pharmacol, 62, pp. 679-684 Pluta, R.M., Oldfield, E.H., Boock, R.J., Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage (1997) J Neurosurg, 87, pp. 746-751 Thomas, J.E., Rosenwasser, R.H., Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: Initial observations regarding the use of intraventricular sodium nitroprusside in humans (1999) Neurosurgery, 44, pp. 48-57 Gabikian, P., Clatterbuck, R.E., Eberhart, C.G., Tyler, B.M., Tierney, T.S., Tamargo, R.J., Prevention of experimental cerebral vasospasm by intracranial delivery of a nitric oxide donor from a controlled-release polymer: Toxicity and efficacy studies in rabbits and rats (2002) Stroke, 33, pp. 2681-2686